Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

HSF2 monoclonal antibody (3E2)

 
ADI-SPA-960-E 100 µg 290.00 USD
Do you need bulk/larger quantities?
 

Product Specification

Alternative Name:HSTF2, Heat shock factor protein 2
 
Clone:3E2
 
Host:Rat
 
Isotype:IgG
 
Immunogen:Recombinant mouse HSF2.
 
UniProt ID:P38533
 
Source:Purified from mouse ascites.
 
Species reactivity:Human, Mouse, Rat
Bovine, Dog, Guinea pig, Hamster, Monkey, Porcine, Rabbit, Sheep
 
Applications:WB
 
Recommended Dilutions/Conditions:Western Blot (4µg/ml, colorimetric)
Suggested dilutions/conditions may not be available for all applications.
Optimal conditions must be determined individually for each application.
 
Application Notes:Western Blot (4µg/ml, colorimetric)
Optimal conditions must be determined individually for each application.
 
Purity Detail:Protein G affinity purified.
 
Formulation:Liquid. In PBS, pH 7.2, containing 50% glycerol and 0.09% sodium azide.
 
Handling:Avoid freeze/thaw cycles.
 
Shipping:Shipped on Blue Ice
 
Long Term Storage:-20°C
 
Scientific Background:HSFs (Heat Shock family of transcription factors), which consists of HSF 1-4, bind to highly conserved Heat shock elements (HSEs) in the promoter regions of heat shock genes, ultimately regulating the expression of Heat shock proteins (Hsps). On exposure to heat shock and other stresses, HSF1 localizes within seconds to discrete nuclear granules and on recovery from stress, HSF1 rapidly dissipates from the stress granules to a diffuse nucleoplasmic distribution.
 
Regulatory Status:RUO - Research Use Only
 
HSF2 monoclonal antibody (3E2) Western blot
Please mouse over
HSF2 monoclonal antibody (3E2) Western blot

Product Toolbox

PRODUCT RESOURCES

Datasheet
MSDS
Certificate of Analysis

RELATED PRODUCTS

By target:
HSF
By biological activity:
HSF Monoclonal antibody
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service

Recommend this page

 
Keep in touch

©2020 Enzo Life Sciences, Inc.,